According to Sun Pharmaceutical Industries latest financial reports the cash on hand of SUNPHARMA is $1.90B, an increase of 25.70% to 2022. At the end of 2022 company had $1.51B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $1.90B | 25.70% |
2022 | $1.51B | 32.33% |
2021 | $1.14B | -12.58% |
2020 | $1.31B | -2.14% |
2019 | $1.34B | - |